Wilmington Savings Fund Society FSB Trims Position in Maximus, Inc. (NYSE:MMS)

Wilmington Savings Fund Society FSB reduced its holdings in Maximus, Inc. (NYSE:MMSFree Report) by 4.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 64,076 shares of the health services provider’s stock after selling 2,729 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Maximus were worth $4,783,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Nordea Investment Management AB acquired a new stake in shares of Maximus in the fourth quarter worth approximately $4,618,000. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock valued at $22,132,000 after buying an additional 83,390 shares in the last quarter. Versor Investments LP grew its holdings in shares of Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after buying an additional 5,789 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Maximus by 12.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after acquiring an additional 102,350 shares in the last quarter. Finally, Citigroup Inc. boosted its position in Maximus by 143.3% during the 3rd quarter. Citigroup Inc. now owns 59,448 shares of the health services provider’s stock worth $5,538,000 after acquiring an additional 35,012 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday.

View Our Latest Analysis on MMS

Maximus Trading Down 0.2 %

NYSE:MMS opened at $69.86 on Friday. The company has a market capitalization of $3.99 billion, a P/E ratio of 15.02 and a beta of 0.72. The stock’s 50 day moving average price is $74.73 and its 200 day moving average price is $83.32. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.49 and a current ratio of 1.72. Maximus, Inc. has a 52 week low of $68.30 and a 52 week high of $93.97.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, research analysts forecast that Maximus, Inc. will post 6.05 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Activity

In other Maximus news, Director Raymond B. Ruddy purchased 3,490 shares of the stock in a transaction dated Thursday, December 12th. The shares were bought at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bruce Caswell acquired 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was acquired at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the purchase, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 7,063 shares of company stock valued at $502,017. Insiders own 1.60% of the company’s stock.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.